We are live on ! Find out more
KFO

Kopp Family Office Portfolio holdings

AUM $163M
1-Year Est. Return 22.57%
This Fund
S&P 500
This Quarter Est. Return
+12.15%
1 Year Est. Return
+22.57%
3 Year Est. Return
+33.98%
5 Year Est. Return
+1.93%
10 Year Est. Return
AUM
$166M
AUM Growth
+$43.3M
Cap. Flow
+$17M
Cap. Flow %
10.21%
Top 10 Hldgs %
94.34%
Holding
23
New
9
Increased
4
Reduced
9
Closed

Sector Composition

Rank Sector Weight
1 Miscellaneous 43.55%
2 Healthcare 28.85%
3 Technology 26.58%
4 Communication Services 1.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWM icon
1
iShares Russell 2000 ETF
IWM
$77.6B
$31.4M 18.9%
+146,400
New +$26M
VEA icon
2
Vanguard FTSE Developed Markets ETF
VEA
$234B
$25.4M 15.27%
+604,545
New +$24.5M
FIVN icon
3
FIVE9
FIVN
$2.37B
$17.9M 10.75%
263,190
+88,012
+50% +$5.52M
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$15.6M 9.38%
136,895
-405,648
-75% -$33.7M
VWO icon
5
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$15.1M 9.06%
+386,175
New +$14.7M
VCEL icon
6
Vericel Corp
VCEL
$2.03B
$14.7M 8.85%
558,413
+5,450
+1% +$130K
NEO icon
7
NeoGenomics
NEO
$2.37B
$14M 8.43%
1,516,313
-22,800
-1% -$213K
JAMF
8
DELISTED
Jamf
JAMF
$13.5M 8.12%
633,773
+10,330
+2% +$227K
TEAM icon
9
Atlassian
TEAM
$48.8B
$6.71M 4.04%
+52,179
New +$8.31M
MITK icon
10
Mitek Systems
MITK
$808M
$2.54M 1.53%
262,255
+8,000
+3% +$84.3K
VRDN icon
11
Viridian Therapeutics
VRDN
$2.52B
$1.88M 1.13%
+64,388
New +$1.48M
WK icon
12
Workiva
WK
$4.13B
$1.82M 1.1%
+21,689
New +$1.68M
INSP icon
13
Inspire Medical Systems
INSP
$2.15B
$1.76M 1.06%
+6,977
New +$1.49M
COHR icon
14
Coherent
COHR
$52.2B
$1.73M 1.04%
+49,319
New +$1.72M
MODN
15
DELISTED
MODEL N, INC.
MODN
$1.68M 1.01%
+41,519
New +$1.56M
IEFA icon
16
iShares Core MSCI EAFE ETF
IEFA
$194B
$157K 0.09%
2,547
-387,375
-99% -$22.8M
ISTB icon
17
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.09B
$96K 0.06%
2,070
-158
-7% -$7.31K
IVV icon
18
iShares Core S&P 500 ETF
IVV
$843B
$86K 0.05%
223
-11
-5% -$4.25K
IEMG icon
19
iShares Core MSCI Emerging Markets ETF
IEMG
$159B
$68K 0.04%
1,455
-302,690
-100% -$13.8M
IAGG icon
20
iShares Core International Aggregate Bond Fund
IAGG
$11.8B
$38K 0.02%
806
-56
-6% -$2.73K
IMTB icon
21
iShares Core 5-10 Year USD Bond ETF
IMTB
$269M
$36K 0.02%
834
IJH icon
22
iShares Core S&P Mid-Cap ETF
IJH
$123B
$27K 0.02%
565
-45
-7% -$2.17K
IJR icon
23
iShares Core S&P Small-Cap ETF
IJR
$107B
$16K 0.01%
164
-5
-3% -$480

Similar funds

Kopp Family Office's Q4 2022 Portfolio in Review

As of Q4 2022, Kopp Family Office held 23 positions worth $166M, up 35% from $123M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Kopp Family Office deployed $17M of net new capital in Q4 2022, opening 9 new positions and adding to 4 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 146,400 shares worth $31.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 28% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $33.7M trimmed.

  • Kopp Family Office's largest Q4 2022 buy was iShares Russell 2000 ETF: 146,400 shares worth $31.4M.
  • Kopp Family Office added most to FIVE9 in Q4 2022, an estimated $5.52M increase.
  • Kopp Family Office's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $33.7M.
  • Kopp Family Office's ten largest holdings make up 94% of its $166M portfolio in Q4 2022.
  • Kopp Family Office opened 9 new positions and closed 0 in Q4 2022.
  • Kopp Family Office's portfolio value rose 35% quarter-over-quarter to $166M.

Based on Kopp Family Office's 13F filing for Q4 2022, filed 14 Feb 2023.